Cellectis (CLLS) Long-Term Deferred Tax (2024 - 2026)

Cellectis' (CLLS) quarterly Long-Term Deferred Tax came in at $382000.0 in Q1 2026, little changed year-on-year from $382000.0 in Q1 2025, and little changed quarter-over-quarter from $382000.0 in Q4 2025.

Cellectis (CLLS) Long-Term Deferred Tax (2024 - 2026) Analysis & Trends

Cellectis' Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $382000.0 for Q1 2026.

  • On a quarterly basis, Long-Term Deferred Tax changed 0.0% year-over-year to $382000.0 in Q1 2026; TTM through Mar 2026 was $382000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $382000.0, changed 0.0% from the prior year.
  • Long-Term Deferred Tax held at $382000.0 in Q1 2026 per CLLS's latest filing, from $382000.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $803000.0 in Q3 2024 and bottomed at $382000.0 in Q4 2024.
  • The 3-year median for Long-Term Deferred Tax is $382000.0 (2024), against an average of $442142.9.
  • Biggest YoY gain for Long-Term Deferred Tax was 0.0% in 2025; the steepest drop was 52.43% in 2025.
  • Year by year, Long-Term Deferred Tax stood at $382000.0 in 2024, then changed by 0.0% to $382000.0 in 2025, then changed by 0.0% to $382000.0 in 2026.
  • Per Business Quant, the three latest CLLS Long-Term Deferred Tax figures stand at $382000.0 (Q1 2026), $382000.0 (Q4 2025), and $382000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Cellectis 281.48 Mn 95.81 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 382,000.00
Dec 31, 2025 382,000.00
Sep 30, 2025 382,000.00
Jun 30, 2025 382,000.00
Mar 31, 2025 382,000.00
Dec 31, 2024 382,000.00
Sep 30, 2024 803,000.00